Report DescriptionAbout IMARC Group

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Global Premenstrual Syndrome Treatment Market Research Report:

The latest report by IMARC, titled “

PremenstrualSyndromeTreatmentMarket:GlobalIndustryTrends,Share,Size,Growth,Opportunity andForecast2023-2028

” " finds that the global online gambling market size reached US$ 1,346 Million in 2022.

Premenstrual syndrome (PMS) treatment involves therapeutic processes to alleviate emotional, physical, and psychological symptoms that women experience, including bloating, breast tenderness, body pain, fatigue, mood swings, and anxiety. These symptoms occur at the end of the luteal phase and subside with menstruation or shortly thereafter. They are often treated by antidepressants, analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), diuretics, ovarian suppression agents, and hormonal contraceptives, which are available over the counter or via prescription. Additionally, novel PMS treatments, including topical gels, creams, capsules, and suppositories, are also used to manage mood imbalances, reduce uterine cramps, and promote muscle relaxation.

Request Free Sample Report: https://www.imarcgroup.com/premenstrual-syndrome-treatment-market/requestsample

Global Premenstrual Syndrome Treatment Market Trends:

The market is primarily driven by the increasing prevalence of PMS and premenstrual dysphoric disorder (PMDD) due to sedentary lifestyles and hectic working schedules of the female working population. In addition, rising awareness among individuals regarding available treatment solutions for PMS disorders represents another major growthinducing factor. Besides this, individuals are adopting nutritional supplements made with plant-based sources to provide relief from PMS.

These supplements contain nutrients, such as calcium, potassium, magnesium, and proteins, that aid in reducing fatigue and easing anxiety and depression. This, coupled with the introduction of smartphone applications that records physiological and emotional changes occurring in the body and sends notification reminders for medication, is positively influencing the market growth. Moreover, the launch of advanced medications with minimal side effects that aid in maintaining the appropriate pH balance in the body is also creating a favorable market outlook. Looking forward, IMARC Group expects the market value to reach US$ 1,683 Million by 2028, exhibiting a CAGR of 3.9% during 2023-2028.

Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).